logo

For the Inventor, By the Inventor

Kalamazoo, MI, United States of America

Richard Charles Thomas

This inventor holds 28 USPTO granted patents, primarily in Antimicrobial Compounds. Top assignees: Pharmacia & Upjohn Company, The Upjohn Co., Pfizer Corporation. Active years: 1982-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Charles Thomas. Retrieved from https://idiyas.com/inventor/richard-charles-thomas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 28

% Patents Active = 89.3

Average Co-Inventor Count = 2.6

ph-index = 9

Forward Citations = 199(Granted Patents)


Location History:

  • Oshtemo Township, Kalamazoo County, MI (US) (1982 - 1990)
  • Kalamazoo, MI (US) (1983 - 2010)

Company Filing History:

goldMedal14 out of 523 
 
Pharmacia & Upjohn Company
 patents
silverMedal11 out of 2,170 
 
The Upjohn Co.
 patents
bronzeMedal2 out of 4,490 
 
Pfizer Corporation
 patents
4. 1 out of 117 
 
Pharmacia & Upjohn
 patents
5. 1 out of 220 
 
Pharmacia Corporation
 patents
where one patent can have more than one assignee

Years Active: 1982-2010

Loading Chart...
Areas of Expertise:
Antimicrobial Compounds
Oxazolidinones
Isoxazolines
Pharmaceuticals
Beta-Lactams
Spectinomycin
Heterocyclic Rings
Anti-AIDS
Anti-HIV-1
Pyrimidines
Bicyclic Structures
28 patents (USPTO):Explore Patents
1. 7645781 - N-aryl-2-oxazolidinone-5-carboxamides and their derivatives (2010-01-12),
2. 7141588 - N-aryl-2-oxazolidinone-5-carboxamides and their derivatives (2006-11-28),
3. 6919329 - N-Aryl-2-oxazolidinone-5-carboxamides and their derivatives (2005-07-19),
4. 6358942 - Phenyloxazolidinones having a c-c bond 4-8 membered heterocyclic rings (2002-03-19),
5. 6313307 - Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings (2001-11-06),
6. 6166056 - Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings (2000-12-26),
7. 6093736 - Isoxazoline derivatives useful as antimicrobials (2000-07-25),
8. 6069141 - Substituted aminophenyl isoxazoline derivatives useful as antimicrobials (2000-05-30),
9. 6051716 - Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings (2000-04-18),
10. 6043248 - Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as (2000-03-28),
11. 5990136 - Isoxazoline derivatives useful as antimicrobials (1999-11-23),
12. 5981537 - Pyrimidine-thioalkyl and alkylether compounds (1999-11-09),
13. 5968962 - Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings (1999-10-19),
14. 5955460 - Oxazolidinone antibacterial agent with tricyclic substituents (1999-09-21),
15. 5952324 - Bicyclic oxazine and thiazine oxazolidinone antibacterials (1999-09-14),

Title: The Innovative Journey of Richard Charles Thomas

Introduction: Richard Charles Thomas, a pioneering inventor based in Kalamazoo, MI (US), has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Richard Charles Thomas holds several patents in various technological domains, including advancements in renewable energy systems, artificial intelligence algorithms, and medical devices.

Career Highlights: Throughout his illustrious career, Richard Charles Thomas has been recognized for his innovative spirit and problem-solving abilities. His inventions have revolutionized industries and improved the quality of life for many.

Collaborations: Richard Charles Thomas has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His partnerships have been instrumental in the successful development and commercialization of his patented technologies.

Conclusion: Richard Charles Thomas stands as a testament to the power of innovation and perseverance in the world of inventing. His dedication to pushing the boundaries of technology continues to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…